Emerging biopharma sponsors drive innovation in clinical trials, and their choice of technology plays an important role in fueling this innovation. Today, sponsors can choose clinical trial technology give the explosion of growth in healthcare technologies.
For many emerging biopharma companies, this occurs after CRO selection. However, treating technology as an afterthought isn’t recommended as it can restrict certain technological capabilities that would otherwise simplify the study planning process.
Sponsors Choose Clinical Trial Technology to Improve Trial Efficiencies
There are various benefits of thinking about technology beforehand. Creating a technology strategy earlier on in the process informs trial design by offering sponsors awareness of their capabilities before a protocol is built. For instance, in certain cases, sponsors may need over 3 months to implement an ePRO build. However, if the biopharma company didn’t consult the tech provider early in the planning process, that time would be omitted from the initial timeline.
By allowing proactive identification and early planning of trial roadblocks, assessing technology beforehand helps emerging biopharma companies complete studies on time. This also allows emerging biopharma companies to develop more patient-centric trials, which is an important feature to demonstrate a drug’s long-term efficacy. Before devising a study design or choosing a CRO, successful sponsors develop technology strategies.
Sponsors that make informed technology decisions do so by researching multiple options and understanding what technology is available before the planning process. With a thorough understanding of available technology, sponsors explain technology preferences to CROs during the CRO selection process.
Disparate systems versus unified platform
Managing study data using disparate technologies consumes time and money for emerging biopharma companies. Although custom integrations are possible, they might compromise some key attributes for sponsors, including flexibility to protocol changes, data oversight, and data integrity.
Here’s how a unified platform alleviates the aforementioned issues:
- Allowing for data changes with no implementation downtime. In addition, allowing for any changes to be reflected across every data instance.
- Offering sponsors with real-time oversight and allowing them to make informed decisions in real-time.
- Providing emerging sponsors with precise data with no data or import failures, enabling them to maintain data integrity.
Clinical PURSUIT’s powerful EDC system for patient studies comes with ingenious productivity tools
ClinicalPURSUIT’s intelligent electronic data capture system tools allow you to easily keep a check on your clinical trial data status.
Schedule a demo of our clinical EDC solutions and being your agile rapid study development today.